Cholera deaths hit their highest reported level since 1999, despite fewer cases
New figures expose a treatment-access gap behind a rising death toll.
Cholera is killing more people even as fewer infections are being reported, exposing a dangerous gap between the tools available to fight the disease and patients' ability to reach them.
Forty-seven countries reported 451,499 cases and 7,870 deaths in 2025, the World Health Organization said September 29. Deaths rose 30%, reaching the highest annual reported total since 1999. Seven countries accounted for around 90% of reported cases and deaths: Angola, Bangladesh, the Democratic Republic of the Congo, Nigeria, South Sudan, Sudan and Yemen.
The figures describe reported disease in 2025, not the total number of infections worldwide or the situation on any one day this week. WHO says surveillance misses a substantial share of the burden.
Access to care is a critical dividing line. More than one in five reported deaths occurred outside health facilities. Among patients treated inside facilities, the global fatality rate remained below 1%, although twelve countries exceeded that benchmark.
Vaccine production has expanded, reaching approximately 80 million doses annually in 2025 from about 30 million in 2022. That improvement does not remove the need for treatment or functioning water systems.
Cholera spreads through food or water contaminated with the bacterium Vibrio cholerae. Most infections are mild or cause no symptoms, but severe disease can produce life-threatening dehydration within hours. WHO's clinical guidance distinguishes cases that can be managed with oral rehydration from severe illness requiring intravenous fluids and other medical treatment.
Its broader prevention guidance places safe water, sanitation and hygiene alongside vaccination. Conflict, displacement and extreme weather can disrupt those protections, while inadequate investment can leave communities exposed even outside an emergency.
Surveillance is another constraint. Rapid tests can help detect a probable outbreak, but laboratory confirmation is needed. A decline in reported cases therefore cannot automatically be read as a comparable fall in transmission: it may also reflect where testing and reporting are functioning.
The international response has a longer-term benchmark. The Global Task Force on Cholera Control's 2030 roadmap seeks a 90% reduction in deaths and elimination in as many as twenty countries. Its strategy combines early containment with a focus on the areas most affected and coordinated support for national plans.
The latest report does not measure whether any particular government has met that goal. It does make the accountability questions more concrete: where did patients die before reaching care, which communities lack reliable water, and whether additional vaccine supply is reaching the places with the greatest burden.
Fewer notifications alone are not a sufficient measure of success. For a preventable, treatable disease, the more consequential test is whether patients can obtain care before dehydration becomes fatal and whether the conditions that allow outbreaks to recur are being repaired.
